Please select an option below to help us tailor your newsletter to best suit your content interests!
Oral Abstract Session: Melanoma/Skin Cancers Sunday, June 6, 2021; 8:00 AM–11:00 AM EDT 9501 Final analysis of overall survival (OS) and relapse-free-survival (RFS) in the intergroup S1404 phase III randomized trial comparing either high-dose interferon (HDI) or ipilimumab to pembrolizumab in patients with high-risk resected melanoma. KF Grossmann, M Othus, SP Patel, et al Take-Home Message The… Read more »
West Cancer Center Palliative Care Physician, Dr. W. Clay Jackson, recently co-authored a case report alongside fellow, Jessica Rich, DO, published in Consultant 360. The two detail a patient case regarding pain in a man with opioid-use-disorder who is taking medication assisted therapy. Pain in a Man With Opioid Use Disorder Who Is Taking… Read more »
New technology and treatments for cancer are ever changing. Researching and providing innovative, curative therapies are a top priority at West Cancer Center. Now women managing cervical cancer will have access to MRI-guided brachytherapy treatment as an option – first available in the MidSouth, right here at West. According to the American Cancer Society, cervical… Read more »
Our West family is proud to have several of our oncologists publish research being presented at the upcoming American Society of Clinical Oncology Meeting, taking place June 4 – 8. West Cancer Center doctors Schwartzberg, Grothey, A. VanderWalde, Vaena, Vidal and ElNaggar are some of the renowned physicians being recognized at this esteemed event for… Read more »
Advancing Cancer Care from the United States to Uzbekistan Just 30 years ago, nearly 27% of hospitals in the country of Uzbekistan didn’t have sewage systems and 17% didn’t even have access to running water. Since the country’s independencefrom Russia in 1991, Uzbekistan has made drastic improvements to its healthcare system to better serve its… Read more »
Wendy Brotherton, Data Scientist, here at West shares insight in digital transformation in healthcare. Our objective is to develop data environments that will help our clinical processes, patient satisfaction, and real-time data sharing for physicians. Click the link to watch the full presentation. https://www.youtube.com/watch?v=H2H23K2I_88
One of our incredible breast medical oncologists, Dr. Gregory Vidal, spearheaded the coordination of Ciara Lee’s long distance journey from Dominica here to Memphis for life-saving brain surgery by Dr. Klimo at Semmes Murphey Clinic, PC! We are so proud of our compassionate providers that go above and beyond to promote health & wellness for our… Read more »
Dr. Jason Porter talks with OncLive about potential sequencing with antibody-drug conjugates (ADCs) and tyrosine kinase inhibitors (TKIs) for HER2+ #lungcancer. Porter states, “The TKIs are oral medications that target HER2 specifically and do not require intravenous infusion. Given the ongoing COVID-19 pandemic, the utility of outpatient therapy with the TKIs may be preferrable to trastuzumab deruxtecan. However,… Read more »
Portnoy says, “It’s been a long time since we’ve had a breakthrough in small cell lung cancer (#SCLC), and we are finally seeing some real concrete improvements in survival with first-line therapy and with those who have progressed on first line therapy. After years of heartbreak and minimal improvement, we’re beginning to see these breakthroughs… Read more »
Dr. Axel Grothey talks with Targeted Oncology how #HER2 has become an actionable target for #GIcancers and potential HER2-targeted treatments in the field, as well as other interesting studies from the role trastuzumab plays in the GI cancer clinical space. Click to read a transcript of this full interview!